Evidence map›Paper›PMID 17639217›Full record

ArticleBulletin of the World Health Organization2007

Planning to improve global health: the next decade of tuberculosis control.

Dermot Maher, Chris Dye, Katherine Floyd, Andrea Pantoja, Knut Lonnroth, Alasdair Reid, Eva Nathanson, Thad Pennas, Uli Fruth, Jane Cunningham and 4 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Lessons from seven decades of antituberculosis drug discovery.Current topics in medicinal chemistry · 2011
    Article
  13. Epidemiology and challenges to the elimination of global tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2010
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dermot MaherStop TB Department, WHO, Geneva, Switzerland.
Chris Dye
Katherine Floyd
Andrea Pantoja
Knut Lonnroth
Alasdair Reid
Eva Nathanson
Thad Pennas
Uli Fruth
Jane Cunningham
Heather Ignatius
Mario C Raviglione
Irene Koek
Marcos Espinal

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Plan to Stop TB 2006-2015 is a road map for policy-makers and managers of national programmes. It sets out the key actions needed to achieve the targets of the Millennium Development Goals relating to tuberculosis (TB): to halve the prevalence and deaths by 2015 relative to 1990 levels and to save 14 million lives. Developed by a broad coalition of partners, the plan presents a model approach combining interventions that can feasibly be supplied on the ground. The main areas of activity set out in the plan are: scaling up interventions to control tuberculosis; promoting the research and development of improved diagnostics, drugs and vaccines; and engaging in related activities for advocacy, communications and social mobilization. Scenarios for the planning process were developed; these looked at issues both globally and in seven epidemiological regions. The scenarios made ambitious but realistic assumptions about the pace of scale-up and implementation coverage of the activities. A mathematical model was used to estimate the impact of scaling up current interventions based on data from studies of tuberculosis biology and from experience with tuberculosis control in diverse settings. The estimated costs of the activities set out in the Global Plan were based on implementing interventions and researching and developing drugs, diagnostics and vaccines; these costs were US$ 56 billion over 10 years. When translated into cost per disability adjusted life year averted, these costs compare favourably with those of other public health interventions. This approach to planning for global tuberculosis control is a valuable example of developing plans to improve global health that has relevance for other health issues.

Indexed as

Global HealthHealthy People ProgramsAIDS-Related Opportunistic InfectionsCommunicable Disease ControlDirectly Observed TherapyFinancing, OrganizedHumansInternational CooperationPrevalenceQuality-Adjusted Life YearsTuberculosisTuberculosis, Multidrug-Resistant

Identifiers

PMID17639217
PMCPMC2636650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.